Make all the money you can now while it's so freaking easy. This Courageousness and Bullishness may only last until the fall.
Conversation
What's to look at? It's a $.349 stock with a TP of $3, nearing phase 3 of it's latest clinical trial (which has a 80% success rating) Get in
1
1
Show replies